SEC FORM
4
SEC Form 4
FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
OMB APPROVAL |
OMB Number: |
3235-0287 |
Estimated average burden |
hours per response: |
0.5 |
|
|
|
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b). |
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
Science Applications International Corp
[ SAIC ]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X |
Director |
|
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
3. Date of Earliest Transaction
(Month/Day/Year) 07/29/2022
|
4. If Amendment, Date of Original Filed
(Month/Day/Year)
|
6. Individual or Joint/Group Filing (Check Applicable Line)
X |
Form filed by One Reporting Person |
|
Form filed by More than One Reporting Person |
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
1. Title of Security (Instr.
3)
|
2. Transaction Date
(Month/Day/Year) |
2A. Deemed Execution Date, if any
(Month/Day/Year) |
3. Transaction Code (Instr.
8)
|
4. Securities Acquired (A) or Disposed Of (D) (Instr.
3, 4 and 5)
|
5.
Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr.
4)
|
7. Nature of Indirect Beneficial Ownership (Instr.
4)
|
Code |
V |
Amount |
(A) or (D) |
Price |
Common Stock |
07/29/2022 |
|
A |
|
11.2165
|
A |
$95.69
|
2,912.067 |
I |
By Key Executive Stock Deferral Plan |
Common Stock |
|
|
|
|
|
|
|
7,046.2607 |
D |
|
Common Stock |
|
|
|
|
|
|
|
30,406 |
I |
By Trust |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivative Security (Instr.
3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Transaction Date
(Month/Day/Year) |
3A. Deemed Execution Date, if any
(Month/Day/Year) |
4. Transaction Code (Instr.
8)
|
5.
Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
3, 4 and 5)
|
6. Date Exercisable and Expiration Date
(Month/Day/Year) |
7. Title and Amount of Securities Underlying Derivative Security (Instr.
3 and 4)
|
8. Price of Derivative Security (Instr.
5)
|
9.
Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
4)
|
10. Ownership Form: Direct (D) or Indirect (I) (Instr.
4)
|
11. Nature of Indirect Beneficial Ownership (Instr.
4)
|
Code |
V |
(A) |
(D) |
Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
Explanation of Responses: |
Remarks: |
|
Hilary L. Hageman, Attorney-in-fact |
08/01/2022 |
|
** Signature of Reporting Person |
Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
* If the form is filed by more than one reporting person,
see
Instruction
4
(b)(v). |
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |
SUBSTITUTE POWER OF ATTORNEY
Under the terms of powers of attorney executed over a period of several years, copies of which were previously filed with the Securities and Exchange Commission, the undersigned, Steven G. Mahon, was appointed attorney-in-fact to act in connection with the filing of Forms 3, 4 and 5 under Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder, for the following directors and officers (collectively, the Section 16 Reporting Persons) of Science Applications International Corporation, a Delaware corporation:
Robert A. Bedingfield
John J. Hamre
Garth N. Graham
Timothy J. Mayopoulos
Milford W. McGuirt
Donna S. Morea
Steven R. Shane
Nazzic S. Keene
Prabu Natarajan
In accordance with the authority granted under each such power of attorney, including the power of substitution, the undersigned hereby appoints Hilary L. Hageman as a substitute attorney-in-fact, on behalf of each Section 16 Reporting Person, with full power of substitution or revocation, to exercise and execute all of the powers granted or conferred in each of the original powers of attorney. By her signature as attorney-in-fact to this Substitute Power of Attorney, Hilary L. Hageman accepts such appointment and agrees to assume from the undersigned any and all duties and responsibilities attendant to his capacity as attorney-in-fact for each Section 16 Reporting Person.
Date: July 12, 2022
/s/Steven G. Mahon
Steven G. Mahon
Attorney-in-fact
I hereby accept this appointment and substitution:
/s/ Hilary L. Hageman
Hilary L. Hageman